Immediate Impact
69 standout
Citing Papers
Lightweight and drift-free magnetically actuated millirobots via asymmetric laser-induced graphene
2024 Standout
Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance
2023 Standout
Works of A. Visvikis being referenced
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Visvikis | 119 | 112 | 250 | 18 | 379 | |
| Payam Entezami | 48 | 57 | 134 | 21 | 377 | |
| Luigi Corcione | 46 | 176 | 175 | 29 | 441 | |
| Jean-Jacques Body | 81 | 80 | 290 | 17 | 393 | |
| Thomas Van Cann | 149 | 23 | 235 | 11 | 355 | |
| Kevin Forsythe | 140 | 110 | 76 | 13 | 416 | |
| Steffen Kargus | 68 | 110 | 252 | 22 | 408 | |
| Jean Verreault | 173 | 99 | 162 | 21 | 428 | |
| Koshiro Ueda | 139 | 193 | 132 | 28 | 374 | |
| Hallie Zietz | 52 | 39 | 157 | 12 | 346 | |
| Mara Ardine | 81 | 21 | 273 | 18 | 356 |
All Works
Loading papers...